Basel, Switzerland—Lonza has announced the adjustment of its Mid-Term Guidance 2022 to reflect the divestment of its former Water Care business unit and to emphasize its focus on growth along the Healthcare Continuum, a press release says.
Adjusted guidance is the following, according to the press release:
- Sales of CHF 7.1 billion
- CORE EBITDA margin of 30.5%
- CORE RONOA 35%
- Double-digit ROIC
Mark Funk, CEO of Lonza, said in the release, “This adjusted Mid-Term Guidance clearly demonstrates our focus on growing our businesses along the Healthcare Continuum while continuing to aim for operational excellence, productivity improvements, and attractive margins.”
The Mid-Term Guidance is based on the present business composition, the present macro-economic environment, current visibility, and constant exchange rates, the press release says.